patient_nbr
int64 135
190M
| Patient context and readmission decision formatted for training
stringlengths 1.99k
2.15k
|
---|---|
48,131,838 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 569. The secondary diagnosis (coded as first three digits of ICD9): 566. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
49,407,813 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 185. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
6,915,888 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 14. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 78. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 250.7. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
|
10,430,154 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Gastroenterology. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 536. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
3,115,566 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 410. Additional secondary diagnosis (coded as first three digits of ICD9): 518. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
|
720,936 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: Surgery-Cardiovascular/Thoracic. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 440. The secondary diagnosis (coded as first three digits of ICD9): 413. Additional secondary diagnosis (coded as first three digits of ICD9): 250.52. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
661,014 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
15,856,002 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Expired. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 507. Additional secondary diagnosis (coded as first three digits of ICD9): 784. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
1,719,279 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 867. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: Steady. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
7,919,802 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 578. The secondary diagnosis (coded as first three digits of ICD9): 285. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
5,041,602 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 88. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 581. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
6,500,556 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Other. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.4. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 420. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
276,606 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 62. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.32. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: Steady. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
815,391 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 255. The secondary diagnosis (coded as first three digits of ICD9): 486. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
18,030,078 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Male. Age: [30-40). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 410. Additional secondary diagnosis (coded as first three digits of ICD9): 8. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
53,612,379 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 250.13. The secondary diagnosis (coded as first three digits of ICD9): V15. Additional secondary diagnosis (coded as first three digits of ICD9): 724. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
558,360 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 8. Additional secondary diagnosis (coded as first three digits of ICD9): 730. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
6,836,652 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Gastroenterology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 558. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 131. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
427,482 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 72. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 788. Additional secondary diagnosis (coded as first three digits of ICD9): 250.82. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
44,279,478 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 574. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 3. Max_glu_serum test result: >300. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Up. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
7,472,070 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.7. The secondary diagnosis (coded as first three digits of ICD9): 440. Additional secondary diagnosis (coded as first three digits of ICD9): 707. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
53,848,278 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 13. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 491. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 999. Number of diagnosis: 5. Max_glu_serum test result: >300. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
5,332,491 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Other. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 402. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 424. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
|
2,519,748 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
5,287,950 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 33. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Up. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
2,024,739 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 584. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 424. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
3,635,847 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 493. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
77,475,465 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 250.03. Number of diagnosis: 5. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
41,606,064 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [20-30). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 277. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 753. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
95,586,993 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 560. The secondary diagnosis (coded as first three digits of ICD9): 997. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 5. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
100,035 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 244. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
608,841 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.03. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
1,059,561 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 340. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
966,042 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 18. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 574. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
1,741,662 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 39. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 577. The secondary diagnosis (coded as first three digits of ICD9): 574. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
3,377,124 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 14. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 730. The secondary diagnosis (coded as first three digits of ICD9): 998. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
90,460,242 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 581. Additional secondary diagnosis (coded as first three digits of ICD9): 786. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
69,318,126 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 82. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 228. Additional secondary diagnosis (coded as first three digits of ICD9): 529. Number of diagnosis: 5. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
5,074,974 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 263. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
4,311,585 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
981,198 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.4. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
720,369 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 530. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
77,574,096 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 188. The secondary diagnosis (coded as first three digits of ICD9): 493. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
4,279,149 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 824. The secondary diagnosis (coded as first three digits of ICD9): 250.82. Additional secondary diagnosis (coded as first three digits of ICD9): E888. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
4,136,517 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Other. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Surgery-Cardiovascular/Thoracic. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 511. Additional secondary diagnosis (coded as first three digits of ICD9): 518. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
80,499,960 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 332. The secondary diagnosis (coded as first three digits of ICD9): 294. Additional secondary diagnosis (coded as first three digits of ICD9): 425. Number of diagnosis: 5. Max_glu_serum test result: >200. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
|
8,354,835 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Gastroenterology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 562. The secondary diagnosis (coded as first three digits of ICD9): 285. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
81,644,544 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Transfer from a hospital. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 595. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Down. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
384,939 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Psychiatry. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 291. The secondary diagnosis (coded as first three digits of ICD9): 493. Additional secondary diagnosis (coded as first three digits of ICD9): 303. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
708,741 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
101,686,554 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 18. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 5. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 296. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
|
2,038,905 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 38. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 562. The secondary diagnosis (coded as first three digits of ICD9): 567. Additional secondary diagnosis (coded as first three digits of ICD9): 560. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
8,348,193 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.7. The secondary diagnosis (coded as first three digits of ICD9): 785. Additional secondary diagnosis (coded as first three digits of ICD9): 711. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
3,168,720 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 510. The secondary diagnosis (coded as first three digits of ICD9): 512. Additional secondary diagnosis (coded as first three digits of ICD9): 8. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
88,614,963 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Transfer from a hospital. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: Steady. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
|
688,347 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 401. The secondary diagnosis (coded as first three digits of ICD9): 305. Additional secondary diagnosis (coded as first three digits of ICD9): 492. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
1,784,367 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 263. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 332. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
86,240,259 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 6. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 8. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
2,604,141 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 67. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 425. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
8,005,509 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 32. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): V15. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
5,039,316 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
83,864,538 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 29. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
112,394,736 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
794,313 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Psychiatry. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 295. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 296. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
357,300 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 1. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 729. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
105,388,416 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 402. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 424. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
1,174,005 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
1,427,400 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.32. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 250.82. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
6,656,679 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 438. The secondary diagnosis (coded as first three digits of ICD9): 780. Additional secondary diagnosis (coded as first three digits of ICD9): 438. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
2,741,004 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 511. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
5,281,155 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Psychiatry. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 295. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 789. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
3,151,539 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [20-30). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Gastroenterology. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 70. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
89,193,870 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.02. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: >300. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
2,498,787 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Surgery-Neuro. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 722. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): V43. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
1,451,637 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 493. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 2. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
279,009 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 722. The secondary diagnosis (coded as first three digits of ICD9): 250.51. Additional secondary diagnosis (coded as first three digits of ICD9): 362. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
511,965 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 560. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 250.4. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
2,283,327 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Obsterics&Gynecology-GynecologicOnco. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 182. The secondary diagnosis (coded as first three digits of ICD9): 280. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
|
6,225,435 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ObstetricsandGynecology. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 642. The secondary diagnosis (coded as first three digits of ICD9): 648. Additional secondary diagnosis (coded as first three digits of ICD9): 654. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
100,605,564 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [20-30). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Clinic Referral. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 30. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 560. Additional secondary diagnosis (coded as first three digits of ICD9): V42. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
80,156,115 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 491. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
780,975 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
8,432,703 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 491. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 244. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
3,492,477 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [10-20). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: Pediatrics. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 3. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.03. The secondary diagnosis (coded as first three digits of ICD9): V15. Additional secondary diagnosis (coded as first three digits of ICD9): V70. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
3,845,322 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
2,596,824 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
4,943,709 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ObstetricsandGynecology. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 625. The secondary diagnosis (coded as first three digits of ICD9): 618. Additional secondary diagnosis (coded as first three digits of ICD9): 618. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
564,732 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 571. The secondary diagnosis (coded as first three digits of ICD9): 70. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
1,121,121 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: Surgery-Cardiovascular/Thoracic. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Down. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
83,363,985 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 9. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 593. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
52,897,581 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 19. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 618. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 625. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
6,539,481 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 63. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 581. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
|
3,053,970 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 996. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
95,326,821 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 24. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
|
2,359,485 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [0-10). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Pediatrics-Endocrinology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.03. The secondary diagnosis (coded as first three digits of ICD9): ?. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 1. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
42,470,721 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
93,479,463 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 22. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
5,014,656 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
|
2,499,588 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 26. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 413. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
|
48,573 |
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 444. Additional secondary diagnosis (coded as first three digits of ICD9): 681. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.